1. Home
  2. FATE vs NFBK Comparison

FATE vs NFBK Comparison

Compare FATE & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • NFBK
  • Stock Information
  • Founded
  • FATE 2007
  • NFBK 1887
  • Country
  • FATE United States
  • NFBK United States
  • Employees
  • FATE N/A
  • NFBK N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • NFBK Major Banks
  • Sector
  • FATE Health Care
  • NFBK Finance
  • Exchange
  • FATE Nasdaq
  • NFBK Nasdaq
  • Market Cap
  • FATE 142.4M
  • NFBK 515.7M
  • IPO Year
  • FATE 2013
  • NFBK 2007
  • Fundamental
  • Price
  • FATE $1.20
  • NFBK $12.25
  • Analyst Decision
  • FATE Hold
  • NFBK Hold
  • Analyst Count
  • FATE 10
  • NFBK 2
  • Target Price
  • FATE $6.75
  • NFBK $13.00
  • AVG Volume (30 Days)
  • FATE 1.7M
  • NFBK 187.2K
  • Earning Date
  • FATE 02-24-2025
  • NFBK 01-22-2025
  • Dividend Yield
  • FATE N/A
  • NFBK 4.33%
  • EPS Growth
  • FATE N/A
  • NFBK N/A
  • EPS
  • FATE N/A
  • NFBK 0.72
  • Revenue
  • FATE $13,447,000.00
  • NFBK $127,026,000.00
  • Revenue This Year
  • FATE N/A
  • NFBK N/A
  • Revenue Next Year
  • FATE N/A
  • NFBK $15.62
  • P/E Ratio
  • FATE N/A
  • NFBK $16.65
  • Revenue Growth
  • FATE N/A
  • NFBK N/A
  • 52 Week Low
  • FATE $1.04
  • NFBK $6.98
  • 52 Week High
  • FATE $8.83
  • NFBK $14.39
  • Technical
  • Relative Strength Index (RSI)
  • FATE 37.03
  • NFBK 58.54
  • Support Level
  • FATE $1.21
  • NFBK $11.62
  • Resistance Level
  • FATE $1.49
  • NFBK $12.25
  • Average True Range (ATR)
  • FATE 0.09
  • NFBK 0.39
  • MACD
  • FATE 0.02
  • NFBK 0.09
  • Stochastic Oscillator
  • FATE 10.34
  • NFBK 100.00

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About NFBK Northfield Bancorp Inc. (Delaware)

Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.

Share on Social Networks: